The Human Cancer PrimaCell™ 4: Breast Tumor Cells is for rapid (7-10 days) isolation and growth of human breast tumor cells from human breast tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 5-7 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 4 System (Cat No. 2-96027):
Human Cancer PrimaCell™ 4: Breast Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 4: Breast Tumor Cells
Human Cancer OptiTDS™ 4: Tissue Dissociation System
Human Cancer PrimaCell™ 4: Breast Tumor Cells Growth Medium
Human Cancer PrimaCell™ 4: Breast Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG. A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies. BMC Cancer. 2012 Jan 10;12:10.
[2] Steck K, McDonnell T, Sneige N, el-Naggar A. Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. 1996 Jun 1;24(2):116-22.